This inventor holds 2 USPTO granted patents. Top assignee: Tohoku University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Hideo Harigae: Innovator in Medical Diagnostics and Treatment
Introduction
Hideo Harigae is a prominent inventor based in Miyagi, Japan. He has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to inflammatory bowel disease and anemia. With a total of 2 patents, Harigae's work is recognized for its innovative approaches to healthcare challenges.
Latest Patents
Harigae's latest patents include a method for diagnosing inflammatory bowel disease, which involves measuring an anti-endothelial cell protein C receptor antibody in a sample collected from a subject. This novel determination method is complemented by a diagnostic probe and kit designed specifically for this purpose. Additionally, he has developed a hematopoiesis-enhancing agent aimed at preventing or treating anemia, particularly refractory anemia. This invention features an S-adenosylmethionine synthase inhibitor as its active ingredient.
Career Highlights
Hideo Harigae is affiliated with Tohoku University, where he has been able to leverage his expertise in medical research and innovation. His work has not only advanced the understanding of inflammatory bowel disease but has also provided new avenues for treating anemia, showcasing his commitment to improving patient outcomes.
Collaborations
Harigae has collaborated with notable colleagues such as Kazuhiko Igarashi and Hiroki Kato, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Hideo Harigae's contributions to medical diagnostics and treatment exemplify the impact of innovative thinking in healthcare. His patents reflect a dedication to addressing critical health issues, making him a noteworthy figure in the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
